DMAA

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Scroll to Statements

Index	-
Market Cap	258.79M
Enterprise Value	258.88M
Income	6.66M
Sales	0.00M
Book/sh	6.96
Cash/sh	0.00
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	2
IPO	Feb 25, 2025

P/E	53.78
Forward P/E	-
PEG	-
P/S	-
P/B	1.53
P/C	25879.00
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.03
Current Ratio	0.03
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	0.20
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	602.84%
Sales Y/Y TTM	-
EPS Q/Q	56.15%
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	23.57%
Insider Trans	0.00%
Inst Own	94.22%
Inst Trans	-
ROA	2.80%
ROE	2.89%
ROIC	2.84%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	0.27%
SMA50	0.51%
SMA200	2.22%
Trades

Shs Outstand	33.72M
Shs Float	18.56M
Short Float	0.41%
Short Ratio	0.64
Short Interest	0.08M
52W High	10.66 0.00%
52W Low	10.17 4.82%
Volatility	0.13% 0.12%
ATR (14)	0.01
RSI (14)	69.35
Beta	0.01
Rel Volume	1.71
Avg Volume	120.01K
Volume	200,303

Perf Week	0.28%
Perf Month	0.47%
Perf Quarter	1.43%
Perf Half Y	2.70%
Perf YTD	2.75%
Perf Year	4.51%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	10.66
Price	10.66
Change	0.00%

Drugs Made In America Acquisition Corp. is a blank check company, which was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on May 23, 2024 and is headquartered in New York, NY.

Chief Executive OfficerMr. Roger Bendelac

CFO & Principal Accounting OfficerMr. Saleem Elmasri CPA

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Drugs Made In America Acquisition Corp

Upgrade your Finviz experience